LexDanaLexDanabeta
Inventor

SAMUEL WADSWORTH

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
A01KAnimal husbandry7%
C07KPeptides7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C12YEnzymes7%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,472,268Gene therapy for treating propionic acidemia202512,344,842Compositions and methods for treating and preventing macular degeneration202512,338,450Gene therapy constructs for treating Wilson disease202511,299,715Use of iNOS inhibitors to increase viral yield in culture2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to GENZYME CORP (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to ULTRAGENYX PHARMACEUTICAL INC (2)· patent assignee history
2025Patents assigned to US HEALTH (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENZYME CORP22022–2025
ULTRAGENYX PHARMACEUTICAL INC22025
US HEALTH12025
Locations
LocationPatentsSpan
US42022–2025